Stratos Wealth Advisors »

Vir Biotechnology shares owned by Stratos Wealth Advisors

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Stratos Wealth Advisors from 13F filings

Historical chart of Stratos Wealth Advisors investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Stratos Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Stratos Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-03-31 $812k 35k 23.27

More positions owned by Stratos Wealth Advisors

Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Growth Etf (VUG)
Procter & Gamble Company (PG)
Amazon (AMZN)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (FFEB)
Eli Lilly & Co. (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)

View all positions for Stratos Wealth Advisors

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
D. E. Shaw & Co
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Principal Financial Group
Dimensional Fund Advisors
Barclays
Millennium Management

View all funds holding Vir Biotechnology